Aclaris Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRS and other ETFs, options, and stocks.About ACRS
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments.
CEONeal S. Walker
CEONeal S. Walker
Employees64
Employees64
HeadquartersWayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded2012
Founded2012
Employees64
Employees64
ACRS Key Statistics
Market cap170.54M
Market cap170.54M
Price-Earnings ratio-1.12
Price-Earnings ratio-1.12
Dividend yield—
Dividend yield—
Average volume1.80M
Average volume1.80M
High today$1.65
High today$1.65
Low today$1.54
Low today$1.54
Open price$1.59
Open price$1.59
Volume589.55K
Volume589.55K
52 Week high$5.17
52 Week high$5.17
52 Week low$1.05
52 Week low$1.05
ACRS News
Simply Wall St 20h
Aclaris Therapeutics' Recent Gains Improve Losses On Insider Purchases Worth US$1.50mInsiders who purchased US$1.50m worth of Aclaris Therapeutics, Inc. ( ) shares over the past year recouped some of their losses after price gained 10% last week...
TipRanks 2d
Aclaris Therapeutics assumed with an Overweight at Piper SandlerPiper Sandler analyst Biren Amin assumed coverage of Aclaris Therapeutics (ACRS) with an Overweight rating and $6 price target The shares are currently trading...
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own ACRS. This list is generated using Robinhood data, and it’s not a recommendation.